Cell-free Assays (IC50/Ki) for PF-02341066 (Crizotinib)

Key TargetIC50 (Cell-free)DescriptionReference
LRRK2 G2019S 980 nM P81 filter-binding method Download PDF
ROS-1 253.7 nM Inhibitory activity assay Download PDF
ROS1 kinase 40–60 nM Kinase activity assay PMC7283026
ALK kinase 150.8 nM in vitro ALK inhibition assay PMC6699152
MST1R 200nM MST1R inhibition assay, KINOMEscan PMC5438060

Cell-based Assay (IC50) for PF-02341066 (Crizotinib)

Cell TypeIC50 (Cell-based)DescriptionReference
MET 11 nmol/L Cell-based assays Download PDF
SU-DIPG-36 cells 31.54 µM Multi-well crystal violet (CV) assay Download PDF
First pATC culture with STRN–ALK fusion 72 nM WST-1 assay, cell counting, Hoechst 33342 staining, Annexin V staining, Transwell Permeable Supports (migration/invasion) Download PDF
Second pATC culture with STRN–ALK fusion 85 nM WST-1 assay, cell counting, Hoechst 33342 staining, Annexin V staining, Transwell Permeable Supports (migration/invasion) Download PDF
pATC culture without STRN–ALK fusion 112 nM WST-1 assay, cell counting, Hoechst 33342 staining, Annexin V staining, Transwell Permeable Supports (migration/invasion) Download PDF
Check the PF-02341066 (Crizotinib) product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Jump to